HK1071758A1 - Pyrazolopyridines as cyclin dependent kinase inhibitors - Google Patents

Pyrazolopyridines as cyclin dependent kinase inhibitors

Info

Publication number
HK1071758A1
HK1071758A1 HK05104996A HK05104996A HK1071758A1 HK 1071758 A1 HK1071758 A1 HK 1071758A1 HK 05104996 A HK05104996 A HK 05104996A HK 05104996 A HK05104996 A HK 05104996A HK 1071758 A1 HK1071758 A1 HK 1071758A1
Authority
HK
Hong Kong
Prior art keywords
pyrazolopyridines
kinase inhibitors
dependent kinase
cyclin dependent
cyclin
Prior art date
Application number
HK05104996A
Other languages
English (en)
Inventor
Timothy J Guzi
Kamil Paruch
Ronald J Doll
Viyyoor M Girijavallabhan
Michael P Dwyer
Kartik M Keertikar
Original Assignee
Schering Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Corp filed Critical Schering Corp
Publication of HK1071758A1 publication Critical patent/HK1071758A1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/437—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Hematology (AREA)
  • Oncology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
HK05104996A 2002-09-19 2005-06-15 Pyrazolopyridines as cyclin dependent kinase inhibitors HK1071758A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US41213802P 2002-09-19 2002-09-19
PCT/US2003/029841 WO2004026872A1 (en) 2002-09-19 2003-09-17 Pyrazolopyridines as cyclin dependent kinase inhibitors

Publications (1)

Publication Number Publication Date
HK1071758A1 true HK1071758A1 (en) 2005-07-29

Family

ID=32030811

Family Applications (1)

Application Number Title Priority Date Filing Date
HK05104996A HK1071758A1 (en) 2002-09-19 2005-06-15 Pyrazolopyridines as cyclin dependent kinase inhibitors

Country Status (19)

Country Link
US (1) US7151104B2 (xx)
EP (1) EP1539750B1 (xx)
JP (1) JP4845380B2 (xx)
KR (1) KR20050072090A (xx)
CN (1) CN100475812C (xx)
AR (1) AR041292A1 (xx)
AT (1) ATE382048T1 (xx)
AU (1) AU2003270846B2 (xx)
CA (1) CA2499593C (xx)
DE (1) DE60318321T2 (xx)
ES (1) ES2297203T3 (xx)
HK (1) HK1071758A1 (xx)
IL (1) IL167432A (xx)
MX (1) MXPA05003059A (xx)
MY (1) MY136840A (xx)
NZ (1) NZ538595A (xx)
TW (1) TWI283243B (xx)
WO (1) WO2004026872A1 (xx)
ZA (1) ZA200502271B (xx)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1386922B1 (en) * 1996-12-03 2012-04-11 Sloan-Kettering Institute For Cancer Research Synthesis of epothilones, intermediates thereof, analogues and uses thereof
US20020058286A1 (en) * 1999-02-24 2002-05-16 Danishefsky Samuel J. Synthesis of epothilones, intermediates thereto and analogues thereof
US7649006B2 (en) 2002-08-23 2010-01-19 Sloan-Kettering Institute For Cancer Research Synthesis of epothilones, intermediates thereto and analogues thereof
WO2004018478A2 (en) 2002-08-23 2004-03-04 Sloan-Kettering Institute For Cancer Research Synthesis of epothilones, intermediates thereto, analogues and uses thereof
EP1799230B1 (en) * 2004-08-27 2012-11-21 Cyclacel Limited Purine and pyrimidine cdk inhibitors and their use for the treatment of autoimmune diseases
PT1859793E (pt) * 2005-02-28 2011-07-05 Eisai R&D Man Co Ltd Uso combinado inovador de um composto de sulfonamida no tratamento oncológico
US20090047365A1 (en) * 2005-02-28 2009-02-19 Eisai R & D Management Co., Ltd. Novel Concomitant Use of Sulfonamide Compound with Anti-Cancer Agent
US7304074B2 (en) * 2005-04-05 2007-12-04 Hoffmann-La Roche Inc. Substituted 1,5-naphthyridine azolinones
US7417053B2 (en) 2005-04-07 2008-08-26 Teijin Pharma Limited Pyrazolo[1,5-a]pyridine derivatives or pharmaceutically acceptable salts thereof
BRPI0607907A2 (pt) * 2005-04-07 2016-11-08 Teijin Pharma Ltd derivado de pirazolo [1,5-a] piridina ou sal do mesmo, composição farmacêutica, inibidor de mapkap-k2, e, agente de tratamento ou prevenção
ATE478852T1 (de) 2005-09-09 2010-09-15 Schering Corp Neue 4-cyano-, 4-amino-, und 4- aminomethylderivative von pyrazoloä1,5- aüpyridinen, pyrazoloä1,5-cüpyrimidinen und 2h- indazolverbindungen und 5-cyano-, 5-amino- und 5- aminomethylderivative von imidazoä1,2-aüpyridinen,und imidazoä1,5-aüpyrazinverbindungen als inhibitoren der cyclinabhänggen kinase
EP2096923B1 (en) * 2006-11-27 2014-01-22 H. Lundbeck A/S Heteroaryl amide derivatives
KR20090031122A (ko) * 2007-09-21 2009-03-25 주식회사 중외제약 인다졸 골격을 함유하는 화합물, 이의 제조방법 및 상기화합물을 함유하는 약제학적 조성물
FR2940284B1 (fr) * 2008-12-19 2011-02-18 Sanofi Aventis Derives de 6-cycloamino-2,3-di-pyridinyl-imidazo°1,2-b!- pyridazine,leur preparation et leur application en therapeutique
US8883819B2 (en) 2011-09-01 2014-11-11 Irm Llc Bicyclic heterocycle derivatives for the treatment of pulmonary arterial hypertension
US9073921B2 (en) 2013-03-01 2015-07-07 Novartis Ag Salt forms of bicyclic heterocyclic derivatives
CA2978518C (en) * 2015-03-27 2023-11-21 Nathanael S. Gray Inhibitors of cyclin-dependent kinases
AU2016357720A1 (en) 2015-11-18 2018-07-05 Genzyme Corporation Biomarker of polycystic kidney disease and uses thereof
AU2017323112B2 (en) * 2016-09-07 2020-11-26 Haihe Biopharma Co., Ltd. Pyrido five-element aromatic ring compound, preparation method therefor and use thereof

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69627195T2 (de) * 1995-11-01 2004-01-29 Novartis Ag Purinderivate und verfahren zu ihrer herstellung
DE69837282T2 (de) 1997-12-13 2007-11-08 Bristol-Myers Squibb Co. VERWENDUNG VON PYRAZOLO Ä 3,4-bÜ PYRIDIN ALS CYCLIN-ABHÄNGIGE KINASE HEMMER
SE9802794D0 (sv) * 1998-08-21 1998-08-21 Astra Ab New compounds
FR2801308B1 (fr) * 1999-11-19 2003-05-09 Oreal COMPOSITIONS DE TEINTURE DE FIBRES KERATINIQUES CONTENANT DE DES 3-AMINO PYRAZOLO-[1,(-a]-PYRIDINES, PROCEDE DE TEINTURE, NOUVELLES 3-AMINO PYRAZOLO-[1,5-a]-PYRIDINES
US20040018192A1 (en) * 2000-02-03 2004-01-29 Toshiaki Wakabayashi Integrin expression inhibitors
CA2432417A1 (fr) 2000-12-20 2002-06-27 Societe De Conseils De Recherches Et D'applications Scientifiques (S.C.R .A.S.) Inhibiteurs de kinases dependantes des cylines (cdk) et de la glycogene synthase kinase-3 (gsk-3)
WO2002069968A1 (en) * 2001-03-08 2002-09-12 Astrazeneca Ab New use
CN1202896C (zh) * 2002-02-07 2005-05-25 北京燕化高新技术股份有限公司 空气分离时纯化空气的方法

Also Published As

Publication number Publication date
AU2003270846B2 (en) 2006-11-23
ATE382048T1 (de) 2008-01-15
MXPA05003059A (es) 2005-05-27
TWI283243B (en) 2007-07-01
US20040097516A1 (en) 2004-05-20
JP2006503060A (ja) 2006-01-26
EP1539750A1 (en) 2005-06-15
AR041292A1 (es) 2005-05-11
CA2499593A1 (en) 2004-04-01
ES2297203T3 (es) 2008-05-01
CN1681816A (zh) 2005-10-12
DE60318321D1 (en) 2008-02-07
TW200409775A (en) 2004-06-16
KR20050072090A (ko) 2005-07-08
DE60318321T2 (de) 2008-12-11
AU2003270846A1 (en) 2004-04-08
US7151104B2 (en) 2006-12-19
MY136840A (en) 2008-11-28
NZ538595A (en) 2006-04-28
IL167432A (en) 2010-05-17
JP4845380B2 (ja) 2011-12-28
CA2499593C (en) 2011-08-16
WO2004026872A1 (en) 2004-04-01
EP1539750B1 (en) 2007-12-26
CN100475812C (zh) 2009-04-08
ZA200502271B (en) 2005-09-19

Similar Documents

Publication Publication Date Title
HK1071757A1 (en) Imidazopyridines as cyclin dependent kinase inhibitors
HK1071758A1 (en) Pyrazolopyridines as cyclin dependent kinase inhibitors
HK1071570A1 (en) Pyrazolopyrimidines as cyclin dependent kinase inhibitors
HK1071569A1 (en) Pyrazolopyrimidines as cyclin dependent kinase inhibitors
AP2048A (en) Diazepinoindole derivatives as kinase inhibitors
IL173381A0 (en) 2-aminophenyl-4-phenylpyrimidines as kinase inhibitors
IL172132A0 (en) Thienopyridone derivatives as kinase inhibitors
IL165515A0 (en) Bisindolyl-maleimid derivatives as kinase inhibitors
AU2003271566A8 (en) Pyrrolopyrazines as kinase inhibitors
HK1072056A1 (en) Imidazopyrazines as cyclin dependent kinase inhibitors
PL375352A1 (en) Azaindole kinase inhibitors
HK1071572A1 (en) PyrazoloÄ1,5-AÜpyrimidine compounds as cyclin dependent kinase inhibitors
EP1496910A4 (en) KINASE INHIBITORS
ZA200606573B (en) Pyrazolopyrimidine-derivatives as cyclin dependent kinase inhibitors
SI1569907T1 (sl) Na nikotinamidu osnovani kinazni inhibitorji
IL173380A0 (en) Pyridinylamino-pyrimidine derivatives as protein kinase inhibitors
IL173200A0 (en) Piperidyl-quinazoline derivatives as tyrosine kinase inhibitors
AP2006003620A0 (en) Imidazopyrazine tyroshine kinase inhibitors
AU2003249442A1 (en) Kinase inhibitors
AU2003254053A8 (en) Pyrazolopyrimidines as protein kinase inhibitors
EP1558609A4 (en) KINASE INHIBITORS
IL172375A0 (en) Chinazoline derivatives as aurora kinase inhibitors
AU2003254051A8 (en) Pyrazolopyrimidines as kinase inhibitors
AU2003261204A1 (en) Pyrazolopyrimidines as kinase inhibitors
PL378116A1 (pl) Heterocykliczne inhibitory kinazy

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20120917